(Q38774032)
Statements
Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial (English)
Michael A Matthay
J Stuart Elborn
Lj Mark Cross
Evie Gardner